Avadel Pharmaceuticals (AVDL) Shares Outstanding (Weighted Average) (2016 - 2020)
Historic Shares Outstanding (Weighted Average) for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q4 2020 value amounting to $53.0 million.
- Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) rose 4168.92% to $53.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $53.0 million, marking a year-over-year increase of 4168.92%. This contributed to the annual value of $53.0 million for FY2020, which is 4168.92% up from last year.
- As of Q4 2020, Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $53.0 million, which was up 4168.92% from $58.2 million recorded in Q3 2020.
- In the past 5 years, Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) ranged from a high of $58.2 million in Q3 2020 and a low of $37.3 million during Q4 2018
- Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $40.8 million (2017), whereas its average is $41.8 million.
- In the last 5 years, Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) soared by 10210057.99% in 2016 and then tumbled by 865.08% in 2018.
- Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) (Quarter) stood at $41.2 million in 2016, then decreased by 1.9% to $40.5 million in 2017, then fell by 7.76% to $37.3 million in 2018, then increased by 0.21% to $37.4 million in 2019, then surged by 41.69% to $53.0 million in 2020.
- Its Shares Outstanding (Weighted Average) was $53.0 million in Q4 2020, compared to $58.2 million in Q3 2020 and $54.3 million in Q2 2020.